The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome
Abstract
Most of the small number of cases of poliomyelitis which occur in countries where Sabin's attenuated poliovirus vaccines are used are temporally associated with administration of vaccine and involve polioviruses of types 2 and 3 (ref. 1). Recent studies have provided convincing evidence that the Sabin type 2 and 3 viruses themselves may revert to a neurovirulent phenotype on passage in man. We report here that a point mutation in the 5' noncoding region of the genome of the poliovirus type 3 vaccine consistently reverts to wild type in strains isolated from cases of vaccine-associated poliomyelitis. Virus with this change is rapidly selected on passage through the human gastrointestinal tract. The change is associated with a demonstrable increase in the neurovirulence of the virus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Soon after vaccination, the majority of vaccinees shed polioviruses with a high frequency of such mutations (Evans et al., 1985, Stern et al., 2017), indicating that the structural stability of domV is under strong positive selection in the human gut.”
From Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence (2020) · cites this paper as Evans et al., 1985
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Complete nucleotide sequences of all three poliovirus serotype genomes
Toyoda, H., Kohara, M., Kataoka, Y., Suganuma, T., Omata, T., Imura, N., & Nomoto, A. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90084-6 · Cited by 418
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.
Nomoto, A., Omata, T., Toyoda, H., Kuge, S., Horie, H., Kataoka, Y., Genba, Y., Nakano, Y., & Imura, N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.19.5793 · Cited by 308
The complete nucleotide sequence of a common cold virus: human rhinovlrus 14
Stanway, G., Hughes, P. J., Mountford, R. C., Minor, P. D., & Almond, J. W. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.20.7859 · Cited by 254
Self-citationStanway, G., Hughes, P. J., Mountford, R. C., Reeve, P., Minor, P. D., Schild, G. C., & Almond, J. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1539 · Cited by 188
Self-citationSome simple computational methods to improve the folding of large RNAs
Jacobson, A. B., Good, L., Simonetti, J., & Zuker, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.45 · Cited by 164
Multiple Genetic Changes Can Occur in the Oral Poliovaccines upon Replication in Humans
Kew, O. M., Nottay, B. K., Hatch, M. H., Nakano, J. H., & Obijeski, J. F. (1981) · Journal of General Virology · doi:10.1099/0022-1317-56-2-337 · Cited by 149
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral pollovirus vaccine
Cann, A. J., Stanway, G., Hughes, P. J., Minor, P. D., Evans, D. M. A., Schild, G. C., & Almond, J. W. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.20.7787 · Cited by 146
Self-citationCritical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3
Evans, D. M. A., Minor, P. D., Schild, G., & Almond, J. W. (1983) · Nature · doi:10.1038/304459a0 · Cited by 111
Self-citationComparative biochemical studies of type 3 poliovirus
Minor, P. D. (1980) · Journal of Virology · doi:10.1128/jvi.34.1.73-84.1980 · Cited by 79
Self-citation
Research works printed but not linked: 2
- Assaad, F. & Cockburn, W. C. Bull Wld Hlth Org. 60, 231–242 (1982).
- Tech. Rep. Ser. Wld Hlth Org. 687, 134 (1983).
Cited by
Items 101–200 of 438
Muslin, C., Joffret, M., Pelletier, I., Blondel, B., & Delpeyroux, F. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005266 · Cited by 86
Genetics, Pathogenesis and Evolution of Picornaviruses
Gromeier, M., Wimmer, E., & Gorbalenya, A. E. (1999) · Elsevier eBooks · doi:10.1016/b978-012220360-2/50013-1 · Cited by 89
“The non-coding genetic elements of picornaviruses have also been shown to carry signals determining virulence (Evans et al., 1985; Duke et al., 1990; Gromeier et al., 1996; Tracy et al., 1996).”
BackgroundAn internal 5'-noncoding region required for translation of poliovirus RNA in vitro
Bieńkowska-Szewczyk, K., & Ehrenfeld, E. (1988) · Journal of Virology · doi:10.1128/jvi.62.8.3068-3072.1988 · Cited by 81
Impaired Binding of Standard Initiation Factors Mediates Poliovirus Translation Attenuation
Ochs, K., Zeller, A., Saleh, L., Bassili, G., Song, Y., Sonntag, A., & Niepmann, M. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.115-122.2003 · Cited by 90
“Attenuation of the poliovirus Sabin vaccine strains is mainly conferred by a single point mutation in the IRES domain V sequence (6, 17, 26, 38).”
BackgroundMethodPolo, J. M., Davis, N., Rice, C. M., Huang, H. V., & Johnston, R. E. (1988) · Journal of Virology · doi:10.1128/jvi.62.6.2124-2133.1988 · Cited by 78
Johnson, V. H., & Semler, B. L. (1988) · Virology · doi:10.1016/0042-6822(88)90393-5 · Cited by 77
Natural mouse IgG reacts with self antigens including molecules involved in the immune response
Berneman, A., Ternynck, T., & Avraméas, S. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220303 · Cited by 77
Asymptomatic circulation of HEV71 in Norway
Witsø, E., Palacios, G. F., Rønningen, K. S., Cinek, O., Janowitz, D., Rewers, M., Grinde, B., & Lipkin, W. I. (2006) · Virus Research · doi:10.1016/j.virusres.2006.07.015 · Cited by 79
“Neurovirulent phenotype determinants have been localized to the enterovirus 5′UTR (De Jesus et al., 2005; Evans et al., 1985; Gromeier et al., 1996, 1999; Rinehart et al., 1997; Romero and Rotbart, 1995; Szendroi et al., 2000).”
BackgroundNucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine
Pollard, S., Dunn, G., Cammack, N. C., Minor, P. D., & Almond, J. W. (1989) · Journal of Virology · doi:10.1128/jvi.63.11.4949-4951.1989 · Cited by 75
Self-citationThe final stages of the global eradication of poliomyelitis
Grassly, N. C. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0140 · Cited by 80
Paralytic poliomyelitis in England and Wales, 1985-91.
Joce, R. E., Wood, D., Brown, D., & Begg, N. T. (1992) · BMJ · doi:10.1136/bmj.305.6845.79 · Cited by 73
Mangada, M. N. M., & Igarashi, A. (1998) · Virology · doi:10.1006/viro.1998.9093 · Cited by 73
Mestecky, J. F., Abraham, R., & Ogra, P. L. O. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-524730-6.50036-1 · Cited by 73
Molecular Mechanisms of Poliovirus Variation and Evolution
Agol, V. I. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-26397-7_8 · Cited by 73
RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence
Chumakov, K. M., Norwood, L. P., Parker, M. L., Dragunsky, E. M., Ran, Y. X., & Levenbook, I. S. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.966-970.1992 · Cited by 72
Famulare, M., Chang, S. T., Iber, J. C., Zhao, K., Adeniji, J. A., Bukbuk, D. N., Baba, M., Behrend, M. R., Burns, C. C., & Oberste, M. S. (2015) · Journal of Virology · doi:10.1128/jvi.01532-15 · Cited by 82
Macadam, A. J., Ferguson, G., Burlison, J., Stone, D., Skuce, R., Almond, J. W., & Minor, P. D. (1992) · Virology · doi:10.1016/0042-6822(92)90565-7 · Cited by 71
Self-citationThe polio-eradication programme and issues of the end game
Minor, P. D. (2011) · Journal of General Virology · doi:10.1099/vir.0.036988-0 · Cited by 75
Self-citationSemler, B. L., Johnson, V. H., & Tracy, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1777 · Cited by 71
Aihara, S., Chun-ming, R., Yu, Y., Lee, T., Watanabe, K., Komiya, T., Sumiyoshi, H., Hashimoto, H., & Nomoto, A. (1991) · Virus Genes · doi:10.1007/bf00571925 · Cited by 71
Haller, A. A., Stewart, S. R., & Semler, B. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1467-1474.1996 · Cited by 70
Attenuation and cell culture adaptation of hepatitis A virus (HAV): a genetic analysis with HAV cDNA
Cohen, J. I., Rosenblum, B., Feinstone, S. M., Ticehurst, J. R., & Purcell, R. H. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5364-5370.1989 · Cited by 70
Sherry, B., & Fields, B. N. (1989) · Journal of Virology · doi:10.1128/jvi.63.11.4850-4856.1989 · Cited by 77
Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus
McGoldrick, A., Macadam, A. J., Dunn, G., Rowe, A., Burlison, J., Minor, P. D., Meredith, J. M., Evans, D. J., & Almond, J. W. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7601-7605.1995 · Cited by 70
Self-citationNeverov, A., & Chumakov, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012537107 · Cited by 68
“Mutant analysis by PCR and restriction enzyme cleavage (MAPREC) is used to measure the frequency of neurovirulent mutations at the 5′ untranslated region (UTR) of the viral genome that correlate with the level of neurovirulence determined by the monkey neurovirulence test.”
BackgroundLiu, Z., Carthy, C. M., Cheung, P., Bohunek, L., Wilson, J. E., McManus, B. M., & Yang, D. (1999) · Virology · doi:10.1006/viro.1999.0048 · Cited by 67
Sean, P., Nguyen, J. H. C., & Semler, B. L. (2009) · Virology · doi:10.1016/j.virol.2009.03.012 · Cited by 65
“A single point mutation in domain V of the poliovirus IRES was shown to attenuate the virus for poliomyelitis (Evans et al., 1985; Kawamura et al., 1989).”
BackgroundViral interference-dominance of mutant viruses over wild-type virus in mixed infections
Whitaker-Dowling, P. A., & Youngner, J. S. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.2.179-191.1987 · Cited by 64
Sonenberg, N. (1990) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-75602-3_2 · Cited by 70
The complete nucleotide sequence of a pathogenic swine vesicular disease virus
Seechurn, P., Knowles, N. J., & McCauley, J. W. (1990) · Virus Research · doi:10.1016/0168-1702(90)90052-d · Cited by 67
Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model.
Logue, C., Bosio, C., Welte, T., Keene, K. M., Ledermann, J., Phillips, A., Sheahan, B., Pierro, D. J., Marlenee, N., Brault, A., et al. (2009) · Journal of General Virology · doi:10.1099/vir.0.008656-0 · Cited by 67
“Previous studies have shown that the secondary structure of the stem–loops in the 59 NTR of other alphavirus genomes plays a role in virus neurovirulence (Evans et al., 1985; Kinney et al., 1993; Logue et al., 2008; Netolitzky et al., 2000).”
BackgroundLana, D. P., Beisel, C. E., & Silva, R. F. (1992) · Virus Genes · doi:10.1007/bf01702563 · Cited by 62
Complications of RNA Heterogeneity for the Engineering of Virus Vaccines and Antiviral Agents
Domingo, E., & Holland, J. J. (1992) · Springer eBooks · doi:10.1007/978-1-4615-3424-2_2 · Cited by 64
Kuhn, R. J., Griffin, D. E., Zhang, H., Niesters, H. G. M., & Strauss, J. H. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7121-7127.1992 · Cited by 60
“Many of the attenuating mutations cause amino acid substitutions in the structural proteins of the virus and probably modulate virus entry into particular populations of host cells, thereby changing tissue tropism, but some attenuating mutations that map to control elements in nontranslated domains have been found (4,…”
BackgroundRecombinant Poliovirus for Cancer Immunotherapy
Gromeier, M., & Nair, S. K. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104655 · Cited by 60
“Size bars represent 1 mm (7, 14) or 100 μm (4, 8, 10, 17).”
BackgroundKaye, K. M., Spriggs, D. R., Bassel‐Duby, R., Fields, B. N., & Tyler, K. L. (1986) · Journal of Virology · doi:10.1128/jvi.59.1.90-97.1986 · Cited by 56
“Five base substitutions in the genome of poliovirus type 3 (P3/Leon/37) may be responsible for the attenuated phenotype of the Sabin vaccine strain (30), and reversion of the Sabin type 3 vaccine strain of poliovirus to a neurovirulent phenotype may correlate with a single nucleotide change in the 5' noncoding region…”
BackgroundSutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00035-5 · Cited by 85
Dobrikova, E. Y., Goetz, C., Walters, R. W., Lawson, S. K., Peggins, J. O., Muszynski, K. W., Ruppel, S., Poole, K., Giardina, S. L., Vela, E. M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06427-11 · Cited by 55
“The Sabin SLD V mutations are critical attenuation determinants, since reversion restores neurovirulence (12, 23).”
BackgroundCytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus
Brown, M. C., & Gromeier, M. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.05.007 · Cited by 55
“The Sabin serotypes each carry critical attenuating point mutations in stem-loop domain V of the IRES [nt positions 480 (type 1); 481 (type 2); 472 (type 3)] [17].”
BackgroundZurbriggen, A., Thomas, C., Yamada, M., Roos, R. P., & Fujinami, R. S. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.1929-1937.1991 · Cited by 55
“For example, increased neurovirulence of the Sabin type 3 poliovirus was associated with a single nucleotide change within the 5' noncoding region (10).”
BackgroundGenomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus.
Calenoff, M. A., Faaberg, K. S., & Lipton, H. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.978 · Cited by 59
Prevalence of vaccine-derived polioviruses in the environment
Yoshida, H., Horie, H., Matsuura, K., Kitamura, T., Hashizume, S., & Miyamura, T. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-5-1107 · Cited by 54
“…: in the case of type 1 viruses, positions 480 and 525 in the 5« non-coding region changed respectively from G to A and from U to C; for type 2, position 481 changed from A to G; and for type 3, position 472 changed from U to C (Kawamura et al., 1989 ; Pollard et al., 1989 ; Evans et al., 1985).”
BackgroundZheng, Z., He, P., Caueffield, D., Neumann, M., Specter, S. C., Baker, C. C., & Bankowski, M. J. (1995) · Journal of Medical Virology · doi:10.1002/jmv.1890470209 · Cited by 59
Pöyry, T. A. A., Kinnunen, L., & Hovi, T. (1992) · Journal of Virology · doi:10.1128/jvi.66.9.5313-5319.1992 · Cited by 54
“In the beginning of stem-loop F, a change of nt 472 from C to U has been shown to be important in the neurovirulence of type 3 polioviruses (7, 39).”
BackgroundCornman, R. S., Boncristiani, H., Dainat, B., Chen, Y., vanEngelsdorp, D., Weaver, D., & Evans, J. D. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-154 · Cited by 64
“Virulence can depend strongly on viral genotype (as evidenced by the effects of specific point mutations on the virulence of human influenza virus [11] and attenuated polioviruses [12]), although host genotype, infection mode, and environment are likely to be important as well.”
BackgroundWang, J., Tsai, H., Chen, P.-F., Lai, Y.-J., Yan, J.-J., Kiang, D., Lin, K.-H., Liu, H., & Su, I. (2000) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00079-2 · Cited by 53
Severity‐Related Molecular Differences among Nineteen Strains of Dengue Type 2 Viruses
Pandey, B. D., & Igarashi, A. (2000) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2000.tb02480.x · Cited by 53
Racaniello, V. R. (1988) · Advances in virus research · doi:10.1016/s0065-3527(08)60519-9 · Cited by 55
Chapman, N. M., Ragland, A., Leser, J. S., Höfling, K., Willian, S., Semler, B. L., & Tracy, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4047-4056.2000 · Cited by 53
“Single base attenuating mutations in enteroviruses revert quickly, as has been demonstrated not only for the PV vaccine strains in humans (16) but in experimental animal studies of coxsackieviruses as well.”
BackgroundDeterminants of Bluetongue Virus Virulence in Murine Models of Disease
Caporale, M., Wash, R., Pini, A., Savini, G., Franchi, P., Golder, M. C., Patterson‐Kane, J. C., Mertens, P., Gialleonardo, L. D., Armillotta, G., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05226-11 · Cited by 51
Zhang, Y., Cao, J., Zhang, S., Lee, A. J., Sun, G., Larsen, C. N., Zhao, H., Gu, Z., He, S., Klem, E. B., et al. (2016) · Virus Evolution · doi:10.1093/ve/vew015 · Cited by 51
Rubin, S. A., Pletnikov, M. V., & Carbone, K. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8037-8042.1998 · Cited by 51
Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan
Yoshida, H., Horie, H., Matsuura, K., & Miyamura, T. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02868-3 · Cited by 52
Stuart, A. D., McKee, T., Williams, P. A., Harley, C., Shen, S., Stuart, D. I., Brown, T. D. K., & Lea, S. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7694-7704.2002 · Cited by 51
Pathogenicity and virulence of hepatitis A virus
Pintó, R. M., Rodríguez, F., Costafreda, M. I., Chavarria-Miró, G., Guix, S., Ribes, E., & Bosch, A. (2021) · Virulence · doi:10.1080/21505594.2021.1910442 · Cited by 50
“instance, for poliovirus it has been proposed that the mutation C472U in the IRES stem-loop V [94] as well as interactions between the stem-loops V and VI, are”
BackgroundGould, A. R., & Eaton, B. T. (1990) · Virus Research · doi:10.1016/0168-1702(90)90062-g · Cited by 52
Johnson, B. J. B., Kinney, R. M., Kost, C. L., & Trent, D. W. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-9-1951 · Cited by 50
“On: Tue, 16 Oct 2018 22:56:25 J. gen. Virol. (1986), 67, 1951-1960.”
Genetic Determinants of Cell Type-Specific Poliovirus Propagation in HEK 293 Cells
Campbell, S. A., Lin, J., Dobrikova, E. Y., & Gromeier, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6281-6290.2005 · Cited by 61
“Evidence for involvement of IRES SLD V in neuroattenuation stems from studies of PV3(S)-associated VAPP, revealing reversion of the IRES mutation at nt 472 to the wt sequence (C3U) (13).”
BackgroundCell-Dependent Role for the Poliovirus 3′ Noncoding Region in Positive-Strand RNA Synthesis
Brown, D., Kauder, S. E., Cornell, C. T., Jang, G. Μ., Racaniello, V. R., & Semler, B. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1344-1351.2004 · Cited by 51
“Determinants of the attenuation phenotypes for the Sabin strains of poliovirus have been mapped to the 5-proximal portion of genomic RNAs of all three strains (4, 8, 14 , 18, 23, 24, 33, 39, 54).”
BackgroundNucleotide sequences important for translation initiation of enterovirus RNA
Iizuka, N., Yonekawa, H., & Nomoto, A. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4867-4873.1991 · Cited by 50
Nemirov, K., Lundkvist, Å., Vaheri, A. I., & Plyusnin, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8793-8800.2003 · Cited by 49
“For instance, the poliovirus type 3 vaccine strain consistently reverted to a neurovirulent phenotype by acquiring the same single nucleotide substitution in the 5 NCR ( 12 ).”
BackgroundMacadam, A. J., Ferguson, G. L., Arnold, C., & Minor, P. D. (1991) · Journal of Virology · doi:10.1128/jvi.65.10.5225-5231.1991 · Cited by 49
Self-citationBessaud, M., Joffret, M., Blondel, B., & Delpeyroux, F. (2016) · Scientific Reports · doi:10.1038/srep38831 · Cited by 49
Picornaviridae: The Enteroviruses (Polioviruses, Coxsackieviruses, Echoviruses)
Kapsenberg, J. G. (1988) · Springer eBooks · doi:10.1007/978-1-4612-3900-0_36 · Cited by 48
Evolution of Virulence in Picornaviruses
Tracy, S., Chapman, N. M., Drescher, K. M., Kono, K., & Tapprich, W. E. (2006) · Springer eBooks · doi:10.1007/3-540-26397-7_7 · Cited by 50
“as its subsequent reversion to neurovirulence upon replication in the gut, correlated primarily with a single nucleotide change in the 5′ NTR (Evans et al. 1985).”
BackgroundInfluentialO’Hagan, D. T. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199222010-00001 · Cited by 47
Isoyama, T., Kamoshita, N., Yasui, K., Iwai, A., Shiroki, K., Toyoda, H., Yamada, A., Takasaki, Y., & Nomoto, A. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-9-2319 · Cited by 47
Malnou, C. E., Pöyry, T. A. A., Jackson, R. J., & Kean, K. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10617-10626.2002 · Cited by 50
Radford, A. D., Sommerville, L. M., Ryvar, R., Cox, M. B., Johnson, D. R., Dawson, S., & Gaskell, R. M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00191-8 · Cited by 47
Kung, C., King, C., Lee, C., Huang, L., Lee, P., & Kao, C. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20761 · Cited by 45
“This finding is unlike that of the neurovirulence of poliovirus type 3 that involve the mutation of C to U at position 472 in 50-NCR (the same stem position of the F-loop as EV71) and the viral load in neurological cells [Evans et al., 1985].”
Guillot, S., Oţelea, D., Delpeyroux, F., & Crainic, R. (1994) · Vaccine · doi:10.1016/0264-410x(94)90307-7 · Cited by 53
Molecular determinants for virulence in coxsackievirus B1 infection
Rinehart, J. E., Gomez, R. M., & Roos, R. P. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3986-3991.1997 · Cited by 45
“We focused on recombinant viruses with a chimeric 59 UTR, since studies involving poliovirus have identified this region as being important in neurovirulence (6, 18).”
BackgroundMethodMuzychenko, A. R., Lipskaya, G. Y., Maslova, S. V., Svitkin, Y. V., Pilipenko, E. V., Nottay, B. K., Kew, O. M., & Agol, V. I. (1991) · Virus Research · doi:10.1016/0168-1702(91)90002-d · Cited by 47
Internalization of human rhinovirus 14 into HeLa and ICAM-1-transfected BHK cells
Grunert, H., Wolf, K., Langner, K.-D., Sawitzky, D., Habermehl, K.-O., & Zeichhardt, H. (1997) · Medical Microbiology and Immunology · doi:10.1007/s004300050039 · Cited by 53
Recent insights into poliovirus pathogenesis
Ohka, S., & Nomoto, A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02200-4 · Cited by 44
Monica, N. L., Klipsky, W. J., & Racaniello, V. R. (1987) · Virology · doi:10.1016/0042-6822(87)90136-x · Cited by 44
Virulence Markers in the 5′ Untranslated Region of Genotype 2 Bovine Viral Diarrhea Virus Isolates
Topliff, C. L., & Kelling, C. L. (1998) · Virology · doi:10.1006/viro.1998.9350 · Cited by 51
Poliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus
Quarleri, J. F. (2022) · GeroScience · doi:10.1007/s11357-022-00672-7 · Cited by 46
Laassri, M., Dragunsky, E. M., Enterline, J. C., Eremeeva, T. P., Ivanova, O. E., Lottenbach, K. R., Belshe, R. B., & Chumakov, K. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2886-2894.2005 · Cited by 45
“These data show that many stool samples taken from healthy children 1 week after OPV immunization contained reversions, consistent with classical observations (5, 16, 17).”
BackgroundResultInfluentialMapping of tissue tropism determinants in coxsackievirus genomes
Harvala, H., Kalimo, H., Dahllund, L., Santti, J., Hughes, P., Hyypiä, T., & Stanway, G. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-7-1697 · Cited by 45
“…the cardiovirulent phenotype of CBV3 maps to a 5«NCR determinant at one or more positions (Tu et al., 1995 ; Dunn et al., 2000), and attenuating mutations of picornaviruses (PVs) map to single nucleotides in the region (Evans et al., 1985 ; Svitkin et al., 1990 ; Ren et al., 1991 ; Minor, 1992).”
BackgroundSelf-citationChen, J., Jing, H., Martín‐Nalda, A., Bastard, P., Riviere, J. G., Liu, Z., Colobrán, R., Lee, D., Tung, W., Manry, J., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211349 · Cited by 44
Genetics of Coxsackievirus Virulence
Chapman, N. M., Ramsingh, A. I., & Tracy, S. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60687-8_11 · Cited by 43
Molecular Aspects of Poliovirus Biology with a Special Focus on the Interactions with Nerve Cells
Blondel, B., Duncan, G., Couderc, T., Delpeyroux, F., Pavio, N., & Colbère-Garapin, F. (1998) · Journal of NeuroVirology · doi:10.3109/13550289809113478 · Cited by 63
“Reversion towards the wild-type genotype at position 472 of the 5'NCR is rapidly selected in the gut of vaccinees (Dunn et al, 1990; Minor and Dunn, 1988), and is found in all isolates from VAPP patients (Evans et al, 1985; Georgescu et al, 1994; Minor, 1992).”
BackgroundZimmermann, H., Eggers, H. J., & Nelsen‐Salz, B. (1997) · Virology · doi:10.1006/viro.1997.8601 · Cited by 42
Chumakov, K. M., Dragunsky, E. M., Norwood, L. P., Douthitt, M., Ran, Y., Taffs, R. E., Ridge, J., & Levenbook, I. S. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890420115 · Cited by 43
Host cell proteins binding to domain IV of the 5' noncoding region of poliovirus RNA
Blyn, L. B., Chen, R., Semler, B. L., & Ehrenfeld, E. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4381-4389.1995 · Cited by 42
“For example, a major determinant in the differential growth rates of Sabin vaccine strains of poliovirus in neuronal cells has been suggested to be reduced translation efficiency caused by a single point mutation in domain V (10, 38, 39).”
BackgroundHuovilainen, A., Hovi, T., Kinnunen, L., Takkinen, K., Ferguson, M. A. J., & Minor, P. D. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-5-1373 · Cited by 40
Self-citationLee, C.-K., Kono, K., Haas, E., Kim, K.-S., Drescher, K. M., Chapman, N. M., & Tracy, S. (2004) · Journal of General Virology · doi:10.1099/vir.0.80424-0 · Cited by 43
“Despite this success, the molecular genetics that naturally caused the phenotype of a highly neurovirulent PV strain (Sabin, 1955) were not determined, although much is understood regarding attenuating mechanisms at work in Sabin PV vaccine strains (Evans et al., 1985; Kawamura et al., 1989; Kohara et al., 1988; Macad…”
BackgroundGroup B Coxsackievirus Virulence
Tracy, S., & Gauntt, C. J. (2008) · Springer eBooks · doi:10.1007/978-3-540-75546-3_3 · Cited by 45
Stability of RNA Virus Attenuation Approaches
Kenney, J., Volk, S. M., Pandya, J., Wang, E., Liang, X.-D., & Weaver, S. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.055 · Cited by 40
Smith, S. M., Markham, R. B., & Jeang, K. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7955 · Cited by 42
Zurbriggen, A., Hogle, J. M., & Fujinami, R. S. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.6.2037 · Cited by 40
“The second area, nucleotides 410-520 in the 5' noncoding region of the genome, was selected because previous studies (26) had shown that mutations in the 5' noncoding region were important determinants of attenuation in poliovirus .”
BackgroundMethodCox, N. J., Kitame, F., Kendal, A. P., Maassab, H. F., & Naeve, C. W. (1988) · Virology · doi:10.1016/0042-6822(88)90118-3 · Cited by 38
Why are vaccines against many human viral diseases still unavailable; an historic perspective?
Tannock, G. A., Kim, H., & Xue, L. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25593 · Cited by 39
“The subsequent application of contemporary molecular technologies has shown that, for OPVs, genetic instability associated with neurovirulence occurs following human passage.(14) The neurovirulence risk can be overcome by the replacement of OPVs with IPVs in vaccination programs.”
BackgroundWeeks-Levy, C., Tatem, J. M., Dimichele, S. J., Waterfield, W. F., Georgiu, A. F., & Mento, S. J. (1991) · Virology · doi:10.1016/0042-6822(91)90576-w · Cited by 37
Poliovirus Biology and Pathogenesis
Racaniello, V. R., & Ren, R. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85208-4_15 · Cited by 37
Miller, F. W., Love, L. A., Biswas, T., McClintock, P. R., Notkins, A. L., & Plötz, P. H. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300509 · Cited by 37
Gowen, B. B., Hickerson, B. T., York, J., Westover, J. B., Sefing, E. J., Bailey, K. W., Wandersee, L., & Nunberg, J. H. (2021) · Journal of Virology · doi:10.1128/jvi.00397-21 · Cited by 36
“lar basis for phenotypic reversion was defined (47, 48).”
BackgroundProlonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemia
Misbah, S. A., Lawrence, P. A., Kurtz, J. B., & Chapel, H. M. (1991) · Postgraduate Medical Journal · doi:10.1136/pgmj.67.785.301 · Cited by 35
Isolation and characterization of recombinants between attenuated and virulent aphthovirus strains
Giraudo, A. T., Sagedahl, A., Bergmann, I. E., TORRE, J. L. L., & Scodeller, E. A. (1987) · Journal of Virology · doi:10.1128/jvi.61.2.419-425.1987 · Cited by 35
“Major determinants of attenuation were located in the 5' half of the viral genome, specifically, in the capsid region of Sabin type I (1, 2, 3) and in the 5'-noncoding region of Sabin type III (9).”
Background
Metadata
- Authors
- Evans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K., & Maizel, J. V.
- Affiliations
- National Institute for Biological Standards and Control (GB)
- University of Leicester (GB)
- National Institutes of Health (US)
- ORCID
- Cann, A. J.
- Venue
- Nature
- Published
- 1985-04
- Volume
- 314
- Issue
- 6011
- Pages
- 548-550
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2044967254
- Cited by
- 440
- References
- 17
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 12 · 2013: 7 · 2012: 3
- FWCI
- 21.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- vaccine-associated poliomyelitis, neurovirulence, point mutations, 5' untranslated region, genetic reversion, vaccine strain selection
- MeSH terms
- Base Sequence, DNA, Viral, Feces, Genes, Viral, Humans, Infant, Mutation, Nucleic Acid Conformation, Poliomyelitis, Poliovirus Vaccine, Oral, RNA, Viral, Structure-Activity Relationship, Vaccination, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.